Many COVID-19 survivors develop long-term conditions after they have recovered from the virus. Considering the have been 250 million reported COVID-19 cases so far, post-COVID-19 conditions will likely incur a massive healthcare burden worldwide. A report released by the IQVIA Institute uses RWE and […]
Report Helps Payers Understand Member Perspectives to Increase Value
A report based on a Zipari/Ipsos survey entitled “Payers Don’t Know What They Don’t Know” helps payers address their knowledge gaps regarding member perspectives and customer experience. This online survey questioned health plan members and representatitves. This report covers perspective gaps […]
Value-based Pricing Programs Given Renewed Focus by Pfizer and Takeda
Value-based pricing and reimbursement models are not common in the United States, but this may change after recent programs by Pfizer and Takeda. These pricing strategies are based upon the value provided to the patient and have long been held back due to insufficient outcome data infrastructures. […]
Healthcare Business Transformation Consortium Launched to Promote Real-Time Analytics for Healthcare Management
SAP and Intel have partnered to launch the Healthcare Business Transformation Consortium (HBTC) to help healthcare systems implement real-time analytics into their decision-making. The use of real-time analytics was bolstered due to the COVID-19 epidemic, but 8 out of 10 healthcare systems reported […]
FDA Warms Up to Real-World Evidence
The COVID-19 pandemic has shifted the FDA’s approach to real-world evidence (RWE) in a positive light, according to Stacy Cline Amin, former chief counsel of the FDA. Although the 21st Century Cures Act of 2016 opened the door to implementation of RWE for approval of new indications in previously […]
Oncology RWE Fitness Assessments Accelerated by Multisource Datasets
In response to an article in Values & Outcomes Spotlight, Mary Tran discusses how a multisource data strategy may streamline relevance assessment of real-world databases. There are no clearly established specifications and criteria to evaluate the fitness of real-world data (RWD) for real-world […]
EMA Issues Guideline on RWE in Registry-Based Studies
The European Medicines Agency (EMA) has released new guidelines for using and generating RWE in registry-based studies. The guideline highlighted a commitment to avoiding bias resulting from non-randomized studies through responsible database usage. Likewise, the EMA guidelines emphasize the need […]
xCures Releases xDECIDE Platform to Personalize Cancer Care Using RWD
Released earlier this month, the xDECIDE platform helps doctors choose the optimal treatment strategy for cancer patients, according to a press release from xCures. The consolidated online platform uses real-world data (RWD), expert recommendations, and an advanced learning network to provide a […]
Clinical Research News Podcast Discusses Solara and LiveSLR
The impact of Cytel’s Solara and LiveSLR technologies on the relationship between forecasting and evidence technology is examined on the podcast Clinical Research News. Anna Forsythe, Vice President of Value and Access at Cytel’s Purple Squirrel Economics, discusses how differing evidence thresholds […]
HTA Submissions and Single-Arm Trials: An ISPOR EUROPE Panel Presentation
On December 2nd (11 AM to 12 PM), the use of single-arm trials for Health Technology Appraisal (HTA) will be discussed in a panel presentation led by Dr. Bart Heeg, Vice President of Health Economics at Cytel. HTA bodies have begun accepting evidence from single-arm trials, but the heterogeneity of […]
